Search by Drug Name or NDC
NDC 55289-0493-30 Docusate Sodium 100 mg/1 Details
Docusate Sodium 100 mg/1
Docusate Sodium is a ORAL CAPSULE in the HUMAN OTC DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is DOCUSATE SODIUM.
MedlinePlus Drug Summary
Stool softeners are used on a short-term basis to relieve constipation by people who should avoid straining during bowel movements because of heart conditions, hemorrhoids, and other problems. They work by softening stools to make them easier to pass.
Related Packages: 55289-0493-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Stool Softeners
Product Information
| NDC | 55289-0493 |
|---|---|
| Product ID | 55289-493_06bd4b19-f28d-2ba0-e063-6394a90a1c23 |
| Associated GPIs | 46500010300110 |
| GCN Sequence Number | 003009 |
| GCN Sequence Number Description | docusate sodium CAPSULE 100 MG ORAL |
| HIC3 | D6S |
| HIC3 Description | LAXATIVES AND CATHARTICS |
| GCN | 09101 |
| HICL Sequence Number | 001326 |
| HICL Sequence Number Description | DOCUSATE SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Docusate Sodium |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Docusate Sodium |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/1 |
| Substance Name | DOCUSATE SODIUM |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M007 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 55289-0493-30 (55289049330)
| NDC Package Code | 55289-493-30 |
|---|---|
| Billing NDC | 55289049330 |
| Package | 30 CAPSULE in 1 BOTTLE, PLASTIC (55289-493-30) |
| Marketing Start Date | 2018-01-12 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |